Array BioPharma To Present At The Jefferies 2015 Global Healthcare Conference
May 26 2015 - 9:00AM
PR Newswire (US)
BOULDER, Colo., May 26, 2015 /PRNewswire/ -- Array BioPharma
Inc. (Nasdaq: ARRY) today announced that its Chief Executive
Officer, Ron Squarer, will present
at the Jefferies 2015 Global Healthcare Conference in New York
City. The public is welcome to participate in the conference
through a webcast on the Array BioPharma
website.
|
Event:
|
|
|
|
Jefferies 2015 Global
Healthcare Conference
|
|
Presenter:
|
|
|
|
Ron Squarer, Chief
Executive Officer
|
|
Date:
|
|
|
|
Tuesday, June 2,
2015
|
|
Time:
|
|
|
|
1:30 p.m. Eastern
Time
|
|
Webcast:
|
|
|
|
www.arraybiopharma.com
|
About Array BioPharma
Array BioPharma Inc. is a
biopharmaceutical company focused on the discovery, development and
commercialization of targeted small molecule drugs to treat
patients afflicted with cancer. Six Phase 3 studies are currently
advancing. These programs include three cancer drugs, binimetinib
(MEK162 / wholly-owned), encorafenib (LGX818 / wholly-owned) and
selumetinib (AstraZeneca). For more information on Array,
please go to www.arraybiopharma.com.
|
CONTACT:
|
Tricia
Haugeto
|
|
Array BioPharma
Inc.
|
|
303-386-1193
|
|
thaugeto@arraybiopharma.com
|
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-jefferies-2015-global-healthcare-conference-300087967.html
SOURCE Array BioPharma Inc.
Copyright 2015 PR Newswire
Array Technologies (NASDAQ:ARRY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Array Technologies (NASDAQ:ARRY)
Historical Stock Chart
From Apr 2023 to Apr 2024
